# Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs Draft Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/assessing-adhesion-with-transdermal-and-topical-delivery-systems-for-andas-draft-guidance-for-industry/2987a560-17ed-4e62-b674-1c17e17f5298

> FDA guidance document: Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs Draft Guidance for Industry. Issue date: April 12, 2023. Get complete insights and analysis.

---

## Details

- Title: Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs Draft Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2023-04-12
- Comment Close Date: 2023-06-12
- Last Changed: 2023-04-14
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2016-D-1254">FDA-2016-D-1254</a>

## Related Documents

- [Topical Dermatologic Corticosteroids:  In Vivo Bioequivalence](https://www.globalkeysolutions.net/guidances/guidance-document/topical-dermatologic-corticosteroids-in-vivo-bioequivalence/7cf691b8-82e3-41a4-a550-b4285ce9a9bf)
- [Assessment of Adhesion for Topical and Transdermal Systems Submitted in New Drug Applications : Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/assessment-of-adhesion-for-topical-and-transdermal-systems-submitted-in-new-drug-applications-draft-guidance-for-industry/2c6ec6df-cd19-4af8-ac74-0ccd1281b8ef)
- [Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/assessing-the-irritation-and-sensitization-potential-of-transdermal-and-topical-delivery-systems-for-andas-draft-guidance-for-industry/1472ed4f-fea1-4017-b0d7-d7fcd5e86e6d)